Immutep Limited

NASDAQ:IMMP

Biotechnology

Healthcare
$0.37 +0.64%

+$0.00 today

Market cap
$55.01M
Beta
2.24
P/E (TTM)
-0.9
EPS (TTM)
-$0.06
52W Low $0.29High $3.53

Volume 3.10M

Average 13.46M

IMMP Other Non-Cash Items

Other non-cash adjustments that reconcile net income to operating cash flow.

Immutep LimitedNASDAQ: IMMP

Other Non-Cash Items · Q2 FY2026 · quarter ended Dec 2025

Other non-cash items turns positive

Q2 FY2026 other non-cash items was A$14.8M, compared with -A$6.19M a year earlier.

Context

  • Other non-cash items amounted to 86.7% of revenue in FY2025, up 76.8 pp from a year earlier.
  • Other non-cash items increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterDec 2025
A$14.8M— QoQ
Last fiscal yearJun 2025
A$4.37M+1051.6% YoY
Other Non-Cash Items past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+339.1%——
1 year+1051.6%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Other Non-Cash Items history

AUD · from the cash flow

Latest · FY2025
4.37M AUD
Year-over-year change
+1051.6%
4-year CAGR
-29.6%

Other Non-Cash Items vs competitors

How IMMP compares with its peers on the latest reported figures

  • Peers report in different currencies, so other non-cash items is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +1051.6% is the 2nd highest of 11, against a peer median of +116.6%.
  • Other non-cash items amounts to 86.7% of revenue for IMMP, versus a peer median of 15.1%.
IMMP Competitors
Other Non-Cash Items for IMMP and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CAPRCapricor Therapeutics, Inc.LTM Mar 2026$75.39B USD+59170678.7%+171.4%—
CABACabaletta Bio, Inc.LTM Mar 2026$16.76M USD+162.2%+72.9%—
EDITEditas Medicine, Inc.LTM Mar 2026$5.85M USD+61.3%—15.1%
IMMPImmutep LimitedFY2025A$4.37M AUD+1051.6%—86.7%
VNDAVanda Pharmaceuticals Inc.LTM Mar 2026$3.74M USD+252.3%—1.7%
PRQRProQR Therapeutics N.V.LTM Mar 2026€3.3M EUR+368.6%—24.5%
ALLOAllogene Therapeutics, Inc.LTM Mar 2026$2.88M USD+124.8%+1.1%—
MREOMereo BioPharma Group plcLTM Mar 2026$2.66M USD-46.0%—532.5%
TRDAEntrada Therapeutics, Inc.LTM Mar 2026$790K USD+108.5%—13.8%
CADLCandel Therapeutics, Inc.LTM Mar 2026$539K USD-91.8%-23.8%—
ACHVAchieve Life Sciences, Inc.LTM Mar 2026$82K USD-96.9%-27.3%—
Peer median (excluding IMMP) —+116.6%+1.1%15.1%

Competitors are the stored peer set for IMMP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

AUD
Metric
FY2021
Jun 2021
FY2022
Jun 2022
FY2023
Jun 2023
FY2024
Jun 2024
FY2025
Jun 2025
Net Income(29.9M)(32.21M)(39.9M)(42.72M)(61.43M)
Depreciation & Amortization2.07M2.06M2.06M2.26M2.39M
Deferred Income Tax(7.29M)0(4.99M)00
Stock-Based Compensation1.7M1.49M2M1.8M1.16M
Change in Working Capital(1.99M)(1.56M)764.6K3.46M(8.54M)
Accounts Receivables(2.83M)(2.25M)(1.61M)601.77K(2.52M)
Inventory0813.92K000
Accounts Payables1.38M1.44M3.27M00
Other Working Capital(543.42K)(1.56M)(900.11K)2.86M(6.02M)
Other Non-Cash Items17.77M(8.04K)4.17M379.87K4.37M
Operating Cash Flow(17.64M)(30.23M)(35.88M)(34.82M)(62.05M)
Capital Expenditures(15.6K)(22.91K)(47K)(932.37K)(45.77K)
Acquisitions (Net)00000
Purchases of Investments000(20.09M)0
Sales of Investments00000
Other Investing Activities0016K(903.15K)(38.49M)
Investing Cash Flow(15.6K)(22.91K)(31K)(21.02M)(38.53M)
Debt Repayment(214.38K)(222.54K)(211.97K)(226.49K)(270.67K)
Common Stock Issued43.31M52.98M80.08M100.24M(164.79K)
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities9.59M(2.43M)(3.83M)(4.83M)(254.46K)
Financing Cash Flow52.68M50.33M76.04M95.18M(525.12K)
Effect of Forex Changes(752.84K)(671.04K)3.3M(967.73K)6.73M
Net Change in Cash34.27M19.4M43.42M38.37M(94.38M)
Free Cash Flow(17.66M)(30.25M)(35.93M)(35.75M)(62.1M)

Immutep Limited

NASDAQ:IMMP

Intrinsic Alpha fair value

Locked

Current Price

$0.37

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.